BACKGROUND: Several biomarkers have been proposed to discriminate sporadic Creutzfeldt-Jakob disease (sCJD) from other dementias and control cases. However, their clinical accuracy depends on the PRNP codon 129 genotype, leaving it unclear how well established markers behave in untested conditions. METHODS: We analyzed 14-3-3, tau, p-tau levels, and the p-tau/tau ratio in a population sample collected from Polish hospitals including nondementia, dementia, and definite sCJD cases and validated their parameters according to previously established cutoffs. Additionally, the correlation between biomarkers and disease duration as well as the influence of the PRNP129 polymorphism are reported. RESULTS: The tau levels and p-tau/tau ratios differed considerably between sCJD and clinically characterized non-CJD cases (p < 0.001). p-tau was only elevated in sCJD when compared to cases without dementia (p < 0.05). Tau and the p-tau/tau ratio showed a sensitivity of 95 and 100%, respectively, in detecting sCJD cases. A negative correlation between tau levels and disease duration, but not the timing of lumbar puncture was observed. CONCLUSION: The present findings confirmed the value of the p-tau/tau ratio as a robust sCJD biomarker and suggest a role for tau as prognostic marker.
BACKGROUND: Several biomarkers have been proposed to discriminate sporadic Creutzfeldt-Jakob disease (sCJD) from other dementias and control cases. However, their clinical accuracy depends on the PRNP codon 129 genotype, leaving it unclear how well established markers behave in untested conditions. METHODS: We analyzed 14-3-3, tau, p-tau levels, and the p-tau/tau ratio in a population sample collected from Polish hospitals including nondementia, dementia, and definite sCJD cases and validated their parameters according to previously established cutoffs. Additionally, the correlation between biomarkers and disease duration as well as the influence of the PRNP129 polymorphism are reported. RESULTS: The tau levels and p-tau/tau ratios differed considerably between sCJD and clinically characterized non-CJD cases (p < 0.001). p-tau was only elevated in sCJD when compared to cases without dementia (p < 0.05). Tau and the p-tau/tau ratio showed a sensitivity of 95 and 100%, respectively, in detecting sCJD cases. A negative correlation between tau levels and disease duration, but not the timing of lumbar puncture was observed. CONCLUSION: The present findings confirmed the value of the p-tau/tau ratio as a robust sCJD biomarker and suggest a role for tau as prognostic marker.
Authors: Anna Villar-Piqué; Matthias Schmitz; Ingolf Lachmann; André Karch; Olga Calero; Christiane Stehmann; Shannon Sarros; Anna Ladogana; Anna Poleggi; Isabel Santana; Isidre Ferrer; Eva Mitrova; Dana Žáková; Maurizio Pocchiari; Inês Baldeiras; Miguel Calero; Steven J Collins; Michael D Geschwind; Raquel Sánchez-Valle; Inga Zerr; Franc Llorens Journal: Mol Neurobiol Date: 2018-07-30 Impact factor: 5.590
Authors: Peter Hermann; Brian Appleby; Jean-Philippe Brandel; Byron Caughey; Steven Collins; Michael D Geschwind; Alison Green; Stephane Haïk; Gabor G Kovacs; Anna Ladogana; Franc Llorens; Simon Mead; Noriyuki Nishida; Suvankar Pal; Piero Parchi; Maurizio Pocchiari; Katsuya Satoh; Gianluigi Zanusso; Inga Zerr Journal: Lancet Neurol Date: 2021-03 Impact factor: 44.182
Authors: Joery Goossens; Maria Bjerke; Hanne Struyfs; Ellis Niemantsverdriet; Charisse Somers; Tobi Van den Bossche; Sara Van Mossevelde; Bart De Vil; Anne Sieben; Jean-Jacques Martin; Patrick Cras; Johan Goeman; Peter Paul De Deyn; Christine Van Broeckhoven; Julie van der Zee; Sebastiaan Engelborghs Journal: Alzheimers Res Ther Date: 2017-07-14 Impact factor: 6.982
Authors: Lieke H H Meeter; Everard G Vijverberg; Marta Del Campo; Annemieke J M Rozemuller; Laura Donker Kaat; Frank Jan de Jong; Wiesje M van der Flier; Charlotte E Teunissen; John C van Swieten; Yolande A L Pijnenburg Journal: Neurology Date: 2018-03-07 Impact factor: 9.910
Authors: Peter Hermann; Philip Haller; Stefan Goebel; Timothy Bunck; Christian Schmidt; Jens Wiltfang; Inga Zerr Journal: Viruses Date: 2022-01-28 Impact factor: 5.048
Authors: Natalia Ermann; Piotr Lewczuk; Matthias Schmitz; Peter Lange; Tobias Knipper; Stefan Goebel; Johannes Kornhuber; Inga Zerr; Franc Llorens Journal: Ann Clin Transl Neurol Date: 2018-05-26 Impact factor: 4.511